The blind mole rat may not be able to see, but its genome could shed light on why it does not develop cancer.
Though uric acid crystals may be the bane of gout patients, scientists have shown that intracellular uric acid plays an important antioxidant role.
The androgen receptor signaling inhibitor XTANDI® has been approved for castration-resistant prostate cancer in Japan.
PTENα, an alternative form of the tumor suppressor PTEN, uses a previously unknown start codon rather than the typical AUG.
A large genome-wide association study (GWAS) in the East Asian population has identified six genetic loci linked to higher risk of colorectal cancer.
Singaporean non-small cell lung cancer patients with EGFR mutations can look forward to new treatment possibilities with Boehringer Ingelheim's Giotrif®.
Jakavi, the only approved oral medication for the blood cancer myelofibrosis, has been introduced in Singapore and 50 other countries.
Higher vitamin D levels are linked to better survival rates in cancer patients, according to a study from China.
By targeting proteins only expressed in cancer cells and reducing drug toxicity, scientists hope to be able to fight cancer better.